Logo image of CMPX

COMPASS THERAPEUTICS INC (CMPX) Stock Earnings Estimates

USA - Nasdaq - NASDAQ:CMPX - US20454B1044 - Common Stock

6.17 USD
+0.01 (+0.16%)
Last: 1/29/2026, 1:51:53 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
CMPX revenue by date.CMPX revenue by date.
850K
-100.00%
7.734M71.995M
830.89%
220.07M
205.67%
350.44M
59.24%
585.42M
67.05%
1.049B
79.19%
1.539B
46.71%
2.118B
37.62%
EBITDA
YoY % growth
CMPX ebitda by date.CMPX ebitda by date.
-40.88M
49.72%
-49.664M
-21.49%
-56.036M
-12.83%
-78.576M
-40.22%
-90.392M
-15.04%
-74.511M
17.57%
-16.463M
77.91%
28.325M
272.05%
123.95M
337.60%
167.63M
35.24%
211.1M
25.93%
226.52M
7.30%
EBIT
YoY % growth
CMPX ebit by date.CMPX ebit by date.
-41.66M
49.12%
-50.363M
-20.89%
-56.625M
-12.43%
-75.114M
-32.65%
-84.25M
-12.16%
-94.532M
-12.20%
11.18M
111.83%
152.23M
1,261.63%
346.01M
127.29%
775.9M
124.24%
1.207B
55.56%
1.709B
41.59%
Operating Margin
CMPX operating margin by date.CMPX operating margin by date.
N/AN/A-6,661.76%N/A-1,089.35%-131.30%5.08%43.44%59.10%73.97%78.43%80.69%
EPS
YoY % growth
CMPX eps by date.CMPX eps by date.
-0.37
69.70%
-0.34
8.11%
-0.37
-8.82%
-0.44
-20.25%
-0.46
-4.33%
-0.42
9.72%
0.08
118.26%
0.66
756.67%
1.54
134.83%
3.16
105.18%
4.40
39.32%
5.87
33.51%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27 Q1 / 28 Q2 / 28 Q3 / 28
EPS
Q2Q % growth
-0.10
8.76%
-0.11
7.26%
-0.11
19.29%
-0.11
-38.83%
-0.11
-13.31%
-0.07
34.47%
-0.06
45.84%
-0.03
74.29%
-0.03
74.44%
0.02
132.17%
0.04
165.00%
0.04
232.14%
Revenue
Q2Q % growth
2.38M6.477M3.06M10.2M
328.57%
20.563M
217.48%
N/AN/AN/A
EBITDA
Q2Q % growth
-22.787M
-42.55%
-19.156M
-10.15%
-19.768M
2.79%
-20.451M
-38.98%
-20.839M
8.55%
-21.247M
-10.92%
-19.176M
2.99%
-13.841M
32.32%
-5.947M
71.46%
N/AN/AN/A
EBIT
Q2Q % growth
-17.962M
-8.38%
-19.234M
-15.80%
-20.08M
4.68%
-21.047M
-33.07%
-23.786M
-32.42%
-21.257M
-10.52%
-19.186M
4.45%
-13.852M
34.19%
-5.957M
74.96%
N/AN/AN/A

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
-0.08 -0.140.0642.98%
Q2 2025
Q2Q % growth
-0.14
-40.00%
-0.12-0.02-12.30%
Q1 2025
Q2Q % growth
-0.12
-50.00%
-0.11-0.01-5.99%
Q4 2024
Q2Q % growth
-0.11 -0.10-0.01-9.93%
Q3 2024
Q2Q % growth
-0.08 -0.120.0430.79%
Q2 2024
Q2Q % growth
-0.10
-11.11%
-0.100.00-3.20%
Q1 2024
Q2Q % growth
-0.08
-33.33%
-0.120.0430.51%
Q4 2023
Q2Q % growth
-0.11
-10.00%
-0.10-0.01-14.56%
Q3 2023
Q2Q % growth
-0.08
33.33%
-0.110.0326.80%
Q2 2023
Q2Q % growth
-0.09
-12.50%
-0.08-0.01-8.36%
Q1 2023
Q2Q % growth
-0.06
14.29%
-0.110.0545.82%
Q4 2022
Q2Q % growth
-0.10
52.38%
-0.110.0112.85%
Q3 2022
Q2Q % growth
-0.12
-20.00%
-0.11-0.01-10.29%
Q2 2022
Q2Q % growth
-0.08 -0.090.016.95%
Q1 2022
Q2Q % growth
-0.07 -0.110.0437.61%
Q4 2021
Q2Q % growth
-0.21 -0.07-0.14-182.57%
Q3 2021
Q2Q % growth
-0.10 -0.130.0321.57%
CMPX Yearly EPS VS EstimatesCMPX Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 2 4
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2025
Q2Q % growth

-100.00%
%
CMPX Yearly Revenue VS EstimatesCMPX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2024 2026 2027 2028 2029 2030 2031 2032 2033 500M 1B 1.5B 2B
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS1.31% 29.71% 1.07% 20.94%
RevenueN/A N/A N/A N/A